Rockville biotech firm kicks off brain cancer vaccine trials
Immunomic Therapeutics, a Rockville-based clinical stage biotech company, began the first phase of a clinical trial of a plasmid DNA, or pDNA, vaccine called ITI-1001. It is evalua…
Immunomic Therapeutics, a Rockville-based clinical stage biotech company, began the first phase of a clinical trial of a plasmid DNA, or pDNA, vaccine called ITI-1001. It is evalua…